clinical research prime

Kids & Teens CMV Vaccine Study
- A Phase 1/2a, Placebo-Controlled, Safety and Immunogenicity Study of mRNA-1647 Cytomegalovirus Vaccine.
- Males and Females ages 9-15 years old.
- Participants will also receive study related treatment at no cost and will be compensated for time and travel.